Goldman Sachs tips ResMed shares to rocket 30% to a record high
The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...
Goldman Sachs starts coverage on ResMed with "buy" rating
Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.
ResMed initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...
Fintel on MSN8d
Piper Sandler Initiates Coverage of ResMed (RMD) with Neutral Recommendation
Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.
Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...
Future Market Insights12d
Global Continuous Positive Airway Pressure (CPAP) Market Poised for Sustained Growth, Reaching USD 900 Million by 2033 rise at a CAGR of 6%
The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...
Mena FN16d
Durable Medical Equipment Market Size, Demand, Forecast To 2033
Examples include mobility AIDS like wheelchairs and scooters, patient support items such as hospital beds and lifts, respiratory equipment like CPAP machines, and bathroom safety tools like shower ...